STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
94
13F, latest reported quarter
What the filings say about ALTO
Insiders, 180 days
+$361.2K net bought
1 buyer
Alto Ingredients insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Alto Ingredients, Inc. insiders bought a net $361.2K of stock across 31 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
20 earlier Form 4 trades (code P or S) here by this insider (20 buys), the last on May 13, 2026.
+13.9% median (+19.0% mean) 90-day return after 19 previous buys.
The trade is 5.8% of the 856,393 shares held after it.
No other insider bought within 30 days.
94 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director NATHAN GILBERT E bought about $207.5K of ALTO on Aug 11, 2026, the largest insider purchase at the company on our record; 94 funds added in the latest 13F quarter.
18 earlier Form 4 trades (code P or S) here by this insider (18 buys), the last on Nov 13, 2024.
+18.2% median (+22.2% mean) 90-day return after 17 previous buys.
The trade is 2.6% of the 769,741 shares held after it.
No other insider bought within 30 days.
94 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director NATHAN GILBERT E bought about $92.2K of ALTO on May 12, 2026, the largest insider purchase at the company since 2022; 94 funds added in the latest 13F quarter.
Nobody has filed for crossing 5%. That is a fact, not missing data.
ALTO planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
ALTO mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
NORTH SQUARE DYNAMIC SMALL CAP FUND
$1.3M position · as of 2026-05-31
0.2%
EA Bridgeway Omni Small-Cap Value ETF
$2.5M position · as of 2026-06-30
0.1%
Small Cap Value Fund
$733.9K position · as of 2026-06-30
0.1%
Goldman Sachs Small Cap Equity Insights Fund
$959.6K position · as of 2026-07-31
0.1%
iShares Micro-Cap ETF
$1.4M position · as of 2026-06-30
0.1%
Goldman Sachs Small Cap Value Insights Fund
$1.2M position · as of 2026-07-31
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $361.2K bought by insiders over 180 days, 94 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$943.3M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ALTO
FY Dec 2025
$917.9M
FY Dec 2024
$965.3M
FY Dec 2023
$1.2B
FY Dec 2022
$1.3B
FY Dec 2021
$1.2B
Jun 2026
$245.7M
Mar 2026
$224.7M
Dec 2025
$232.0M
Sep 2025
$241.0M
Jun 2025
$218.4M
Mar 2025
$226.5M
Dec 2024
$236.3M
Sep 2024
$251.8M
At each fiscal year end
Single quarter
Net margin, TTM
+4.1%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ALTO
FY Dec 2025
+0.0%
FY Dec 2024
-0.0%
FY Dec 2023
-2.4%
FY Dec 2022
-3.2%
FY Dec 2021
+3.7%
Jun 2026
+4.8%
Mar 2026
+1.9%
Dec 2025
+3.7%
Sep 2025
+5.9%
Jun 2025
-5.0%
Mar 2025
-5.2%
Dec 2024
+7.3%
Sep 2024
-1.0%
At each fiscal year end
Single quarter
Free cash flow, TTM
$49.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ALTO
FY Dec 2025
$8.6M
FY Dec 2024
-$14.6M
FY Dec 2023
-$7.5M
FY Dec 2022
-$31.7M
FY Dec 2021
$10.4M
Jun 2026
$17.9M
Mar 2026
$3.3M
Dec 2025
$7.6M
Sep 2025
$21.2M
Jun 2025
-$1.3M
Mar 2025
-$18.8M
Dec 2024
-$11.1M
Sep 2024
$18.1M
At each fiscal year end
Single quarter
Debt to equity
0.30x
long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end); equity 2026-06-30
Debt to equity ALTO
FY Dec 2025
0.32x
FY Dec 2024
0.49x
FY Dec 2023
0.36x
FY Dec 2022
0.28x
FY Dec 2021
0.20x
Jun 2026
0.30x
Mar 2026
0.36x
Dec 2025
0.32x
Sep 2025
0.53x
Jun 2025
0.65x
Mar 2025
0.60x
Dec 2024
0.49x
Sep 2024
0.38x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.84x
TTM operating cash flow over long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end)
Cash flow to debt ALTO
FY Dec 2025
0.17x
FY Dec 2024
-0.03x
FY Dec 2023
0.22x
FY Dec 2022
0.07x
FY Dec 2021
0.39x
Jun 2026
0.84x
Mar 2026
0.40x
Dec 2025
0.17x
Sep 2025
-0.05x
Jun 2025
-0.08x
Mar 2025
-0.18x
Dec 2024
-0.03x
Sep 2024
0.18x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+16.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ALTO
FY Dec 2025
+0.0%
FY Dec 2024
-0.0%
FY Dec 2023
-10.0%
FY Dec 2022
-13.1%
FY Dec 2021
+13.8%
Jun 2026
+16.5%
Mar 2026
+6.9%
Dec 2025
+0.0%
Sep 2025
+3.6%
Jun 2025
-3.3%
Mar 2025
-0.0%
Dec 2024
-0.0%
Sep 2024
-13.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ALTO
FY Dec 2025
+0.0%
FY Dec 2024
-0.0%
FY Dec 2023
-6.3%
FY Dec 2022
-8.9%
FY Dec 2021
+9.2%
Jun 2026
+9.8%
Mar 2026
+4.0%
Dec 2025
+0.0%
Sep 2025
+2.2%
Jun 2025
-1.9%
Mar 2025
-0.0%
Dec 2024
-0.0%
Sep 2024
-8.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
effective tax rate -1%, not meaningful
Return on invested capital ALTO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+10.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed ALTO
FY Dec 2025
+2.2%
FY Dec 2024
-14.1%
FY Dec 2023
-6.0%
FY Dec 2022
-15.0%
FY Dec 2021
+10.0%
Jun 2026
+10.2%
Mar 2026
+5.4%
Dec 2025
+2.2%
Sep 2025
-11.0%
Jun 2025
-15.6%
Mar 2025
-13.8%
Dec 2024
-14.1%
Sep 2024
-7.6%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
5.47x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ALTO
FY Dec 2025
16.94x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
7.89x
Jun 2026
8.38x
Mar 2026
12.74x
Dec 2025
16.94x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$341.7M
market value at close 2026-10-27 on 2026-08-06 shares, plus long-term 2026-06-30 plus current 2025-12-31 (6 months older than the period end), minus cash 2026-06-30
Enterprise value ALTO
FY Dec 2025
$279.0M
FY Dec 2024
$194.7M
FY Dec 2023
$272.3M
FY Dec 2022
$262.6M
FY Dec 2021
$367.6M
Jun 2026
$494.8M
Mar 2026
$443.4M
Dec 2025
$279.0M
Sep 2025
$169.4M
Jun 2025
$195.0M
Mar 2025
$188.9M
Dec 2024
$194.7M
Sep 2024
$190.6M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+17.3%
TTM free cash flow over market value at close 2026-10-27
FCF yield ALTO
FY Dec 2025
+3.9%
FY Dec 2024
-12.2%
FY Dec 2023
-3.7%
FY Dec 2022
-14.9%
FY Dec 2021
+3.0%
Jun 2026
+11.3%
Mar 2026
+8.2%
Dec 2025
+3.9%
Sep 2025
-12.0%
Jun 2025
-14.7%
Mar 2025
-34.5%
Dec 2024
-12.2%
Sep 2024
+2.7%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
prior-year trailing EPS was a loss, growth undefined
PEG, trailing ALTO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ALTO ranks highest on financial health (85th percentile) and profitability (74th), and lowest on growth (30th), among Materials peers.
Profitability
74
Inputs
Return on equity+16.5% · 75 pct, sector of 100
Return on assets+9.8% · 83 pct, sector of 120
Return on invested capitaleffective tax rate -1%, not meaningful
Return on capital employed+10.2% · 64 pct, sector of 96
Financial health
85
Inputs
Debt to equity0.30x · 74 pct, sector of 104
Cash flow to debt0.84x · 96 pct, sector of 103
Growth
30
Inputs
Revenue growth, YoY-4.9% · 30 pct, sector of 128
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
70
Inputs
Net Form 4 buying (codes P and S), 180d$361K · 85 pct, sector of 80
Insider buyers, 180d1 · 56 pct, sector of 80
Institutional and government
43
Inputs
Funds adding, latest quarter94 · 43 pct, sector of 118
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
54
Inputs
Short interest, % of float+8.6% · 23 pct, sector of 143
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
New text in Risk Factors, latest 10-K+13.6% · 38 pct, sector of 111
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ALTO filings, in plain words
Are Alto Ingredients insiders buying or selling ALTO?
In the 180 days to 2026-10-28, Alto Ingredients insiders were net buyers, a net $361.2K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-28, Alto Ingredients insiders were net buyers of ALTO, a net $361.2K across purchases and sales reported on Form 4 by 1 buyer. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.